» Articles » PMID: 30668842

The Time is Now: a Call for Action to Translate Recent Momentum on Tackling Tropical Snakebite into Sustained Benefit for Victims

Overview
Date 2019 Jan 23
PMID 30668842
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Like the other WHO-listed Neglected Tropical Diseases (NTDs), snakebite primarily affects rural, impoverished tropical communities that lack adequate health resources. The annual 138 000 deaths and 400 000 disabilities suffered by these subsistence farming communities means that snakebite is an additional cause and consequence of tropical poverty. Unlike most of the NTDs, however, snakebite is a medical emergency, and requires rapid treatment in a hospital equipped with effective antivenom, beds and appropriately trained staff. The lack of such facilities in the remote areas most affected by snakebite, and the high treatment costs, explains why most victims, particularly in sub-Saharan Africa, consult traditional healers rather than seek hospital care. Whilst affordable, there is no evidence that traditional treatments are effective. The number of snakebite victims that die, unregistered, in the community is threefold higher than hospital-recorded deaths. After decades of inertia, WHO benefitted from advocacy interventions and the support of key agencies, including Médecins Sans Frontières, the Wellcome Trust, the Kofi Annan Foundation and the Global Snakebite Initiative, to recently institute transformative actions for reducing the public health burden of tropical snakebite. It is imperative that WHO and the other stakeholders now gain the support and investment of governments, research funders and donor agencies to ensure that this recent momentum for change is translated into sustained benefit to snakebite victims.

Citing Articles

The Venom of : Proteomics, Neurotoxic Effect and Neutralization by Antivenom.

Ivanovic S, Resetar Maslov D, Rubic I, Mrljak V, Zivkovic I, Borozan N Vet Sci. 2024; 11(12).

PMID: 39728945 PMC: 11680118. DOI: 10.3390/vetsci11120605.


The Toxin Diversity, Cytotoxicity, and Enzymatic Activity of Cape Cobra () Venom.

Luddecke T, Avella I, Damm M, Schulte L, Eichberg J, Hardes K Toxins (Basel). 2024; 16(10).

PMID: 39453214 PMC: 11511112. DOI: 10.3390/toxins16100438.


Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors.

Clare R, Dawson C, Westhorpe A, Albulescu L, Woodley C, Mosallam N Front Pharmacol. 2024; 14:1328950.

PMID: 38273820 PMC: 10808794. DOI: 10.3389/fphar.2023.1328950.


ADDovenom: Thermostable Protein-Based ADDomer Nanoparticles as New Therapeutics for Snakebite Envenoming.

Menzies S, Arinto-Garcia R, Amorim F, Cardoso I, Abada C, Crasset T Toxins (Basel). 2023; 15(12).

PMID: 38133177 PMC: 10747859. DOI: 10.3390/toxins15120673.


Stakeholder perspectives from 15 countries in Africa on barriers in snakebite envenoming research and the potential role of research hubs.

Stienstra Y, Aglanu L, Schurer J, Mijumbi R, Mbonigaba J, Habib A PLoS Negl Trop Dis. 2023; 17(12):e0011838.

PMID: 38091347 PMC: 10752511. DOI: 10.1371/journal.pntd.0011838.


References
1.
Williams S, Wijesinghe C, Jayamanne S, Buckley N, Dawson A, Lalloo D . Delayed psychological morbidity associated with snakebite envenoming. PLoS Negl Trop Dis. 2011; 5(8):e1255. PMC: 3149015. DOI: 10.1371/journal.pntd.0001255. View

2.
Gutierrez J, Calvete J, Habib A, Harrison R, Williams D, Warrell D . Snakebite envenoming. Nat Rev Dis Primers. 2017; 3:17063. DOI: 10.1038/nrdp.2017.63. View

3.
Harrison R, Oluoch G, Ainsworth S, Alsolaiss J, Bolton F, Arias A . Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa. PLoS Negl Trop Dis. 2017; 11(10):e0005969. PMC: 5646754. DOI: 10.1371/journal.pntd.0005969. View

4.
Habib A, Kuznik A, Hamza M, Abdullahi M, Chedi B, Chippaux J . Snakebite is Under Appreciated: Appraisal of Burden from West Africa. PLoS Negl Trop Dis. 2015; 9(9):e0004088. PMC: 4580425. DOI: 10.1371/journal.pntd.0004088. View

5.
Warrell D . Unscrupulous marketing of snake bite antivenoms in Africa and Papua New Guinea: choosing the right product--'what's in a name?'. Trans R Soc Trop Med Hyg. 2008; 102(5):397-9. DOI: 10.1016/j.trstmh.2007.12.005. View